Industry: Pharmaceuticals (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2018-09-10 | New | $25,998,130 | $25,998,130 | Equity Only | 06b | SEC link |
| 2017-01-31 | New | $6,615,000 | $6,615,000 | Debt Only | 06b | SEC link |
| 2015-07-21 | Amended | $21,000,000 | $1,000,000 | Equity Only | 06b | SEC link |
| 2015-03-12 | New | $20,000,000 | $20,000,000 | Equity Only | 06b | SEC link |
| 2012-06-18 | Amended | $48,524,067 | $23,224,066 | Equity Only | 06 | SEC link |
| 2010-12-06 | Amended | $25,300,001 | $15,180,001 | Equity Only | 06 | SEC link |
| 2010-01-05 | New | $10,120,000 | $10,120,000 | Equity Only | 06 | SEC link |
| 2009-11-12 | New | $999,999 | Unknown | Debt Only | 06 | SEC link |
| 2007-11-19 | Paper Filing | Unknown | Unknown | Other | Not Available | |
| 2007-01-10 | Paper Filing | Unknown | Unknown | Other | Not Available |
| Name | Role |
|---|---|
| James Barrett | Director |
| Ashutosh Chilkoti | Director |
| Guy Fish | Director |
| Michael Gutch | Director |
| Nancy Hutson | Director |
| Robert Ingram | Director |
| Justin Klein | Director |
| Thomas K Laundon | Executive |
| Caroline Loewy | Director |
| Jonathan Mow | Director, Executive |
| Bibhash Mukhopadhyay | Director |
| Christopher Prior | Director, Executive |
| Douglas Reed | Director |
| Tyrell Rivers | Director |
| Craig Rosen | Director |
| John Sharp | Executive |
| Will Shen | Director |
| Joel Sussman | Executive |
| Clay Thorp | Director |
| Linda Tufts | Director |
| Asish K. Xavier | Director |